Seeking Alpha

BMRN
BioMarin Pharmaceutical Inc. - NASDAQ

4/19/2014, 12:22 AM ET
Quote & Analysis Breaking News StockTalk
bmrn chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
BMRN vs. ETF Alternatives
Company Description

Biomarin Pharmaceutical, Inc., develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of four product candidates Naglazyme, Kuvan, Aldurazyme and Firdapse.

Sector: Healthcare
Industry: Biotechnology
Country: United States